• Clinical Insights

February 2024 drug trend report

Feb 1st, 2024

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to learn more.

Brand name drug launches*

Exxua (Gepirone ER)

  • Indicated for: Treatment of major depressive disorder (MDD) in adults.
  • Dosage form: Oral extended-release tablets.
  • Status: Expected early 2024.

Generic drug launches*

Risperdal Consta® (Risperidone ER injectable powder kit)

  • Indicated for: Treatment of schizophrenia and other behavioral health conditions, such as bipolar disorder.
  • Dosage form: Long-acting injection.
  • Status: Available now.

Current drug shortages*

Brand:

Advair Diskus 100/50, 250/50 and 500/50

  • Indicated for: Treatment of asthma and/or chronic obstructive pulmonary disease (COPD).
  • Status: Recovery TBD.

Zyprexa Relprevv

  • Indicated for: Treatment of schizophrenia in adults.
  • Status: Estimated recovery June 2024.

Generic:

Buproprion XL

  • Indicated for: Treatment of depression.
  • Status: Recovery TBD.

Naltrexone

  • Indicated for: Treatment of alcohol and/or opioid use disorder.
  • Status: Recovery TBD.

Lidocaine 5% patches

  • Indicated for: Localized pain control and/or postherpetic neuralgia.
  • Status: Recovery TBD.

*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.

Recent Posts


  • Blog Post
Retail pharmacy challenges highlight the need for reliable, uninterrupted pharmacy care

Inconsistent hours, long lines and poor customer service have been an all-too-familiar experience for retail pharmacy consumers in recent years. Ongoing staffing shortages and increased demand for pharmacy support –...

  • Pharmacy Openings
Announcing four new pharmacy openings!

We’re excited to announce the opening of four pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Genoa in the News
Genoa Healthcare® Chief Executive Officer provides industry outlook in Chain Drug Review article

In the health care industry in 2024, pharmacy teams will continue to play a critical role in providing care in areas with limited access to pharmacy services. Genoa Healthcare Chief...

  • Clinical Insights
February 2024 drug trend report

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...